Newsletter
July 2022
GloPID-R’s scientific activity in the spotlight
Dr. Alice Norton,
Scientific Manager, GloPID-R
As the head of GloPID-R’s team of scientists and policy specialists, I am pleased to have the opportunity to shine the spotlight on GloPID-R’s scientific activity during what has been an especially productive year thus far.
Many of our readers are participants in one or more of GloPID-R’s five working groups. Our reinvigorated Clinical Trial Networks & Funders (CTN&F) group has gained momentum as well as many new members. These representatives of clinical trial networks and funders will meet in late September to finalize the development of a living roadmap of principles, standards and actions for funders, which will be presented at the GloPID-R General Assembly meeting in Berlin in October. We hope to make it available publicly in 2023.
GloPID-R news
Progress in the implementation of GloPID-R’s regional hub strategy
In 2021, GloPID-R initiated a new strategy to create regional hubs with the aim of improving coordination and efficiency in the funding of research on infectious diseases with pandemic potential.
In-person meeting for GloPID-R’s Executive Board
The GloPID-R Executive Board met on May 31 for the first time in person since October 2019. The meeting was hosted by the European Commission in Brussels.
Monkeypox activity among the GloPID-R membership
Throughout June, GloPID-R has shared reports on the 2022 monkeypox outbreak with our membership. We are currently mapping our members’ activity and interest in funding research into this emerging infectious disease threat.
Update on our working groups
This new feature of the newsletter brings you information about the developments and current focus of each of the GloPID-R working groups. The outputs highlighted in the article will be presented at the GloPID-R General Assembly on October 19-20, 2022 in Berlin.
Member news
ANRS | Emerging Infectious DiseasesCoordination of the ‘Be Ready’ project (June 2022 – June 2025)
Considering its international engagement for global pandemic preparedness and response, the European Commission has decided to entrust ANRS | Emerging Infectious Diseases with the coordination of the Coordinating and Supporting Action (CSA) ‘Be Ready’…
APPRISEJune Newsletter
Catch up with news from APPRISE
CEPI“The path out of the pandemic requires more vaccine research.”
A word from Dr. Melanie Saville is CEPI’s Executive Director of Vaccine Research and Development
CIHRUpdates from the Canadian Institutes of Health Research (CIHR) on COVID-19 funding and improving clinical trials
European CommissionFirst calls for proposals under the Global Health EDCTP3 Joint Undertaking
On May 10, the Global Health EDCTP3 Joint Undertaking published its 2022 Work Programme.
ERINHAERINHA is looking for a Scientific Project Manager
GloPID-R observer ERINHA is looking for a Scientific Project Manager to join the scientific team at their Central Coordinating Unit in Paris
Instituto de Salud Carlos IIITwo recent publications from the National Center of Epidemiology (ISCIII)
Research Council of NorwayThree Projects on Antimicrobial Resistance from a One Health Perspective funded by the RCN
The Research Council of Norway has funded three Collaborative Projects that will generate new knowledge about measures that can help us to understand, manage and prevent the development of antimicrobial resistance (AMR) from a One Health perspective.
Funding calls
CEPIGlobal opportunities to prepare for future pandemics
Apply to CEPI’s calls to advance vaccine development against emerging infectious disease threats. Funding opportunities available in mRNA vaccine platform technology, thermostable vaccines, and the use of computational modelling to identify or predict target antigens.
ERINHAISIDORe Access Call Dedicated To SARS-CoV-2 and COVID-19
Events
Community-based Participatory Research: Good Science for Appropriate Response
ANRS | Emerging Infectious Diseases will once again participate in this two-yearly event organized by the International Aids Society (IAS). The conference will take place, in person and virtually, in Montreal, Canada from July 29 to August 2.
World Health Summit 2022
The 2022 edition of the World Health Summit (WHS) will take place on October 16-18 in Berlin, Germany in person and virtually.
This will be a high-level meeting and the first summit organized in collaboration with WHO. A joint WHS-WHO event is planned to take place every three years in the future.
GloPID-R General Assembly 2022
The GloPID-R General Assembly will be held immediately following the WHS, on October 19-20 in Berlin.
This will be the first in-person GloPID-R General Assembly since January 2019, and we sincerely look forward to welcoming our members, observers and stakeholders from all corners of the globe.
Your invitation and full information have been sent to you.
Please contact Kristina Ruze with any queries.
The Global Health Network Conference 2022
Under the theme ‘Enabling Health Research in Every Healthcare Setting’, this conference aims to bring together health research teams, organisations, health-workers, policy makers and practitioners to explore together how health research can be embedded into every healthcare setting. The conference on 24-25 November 2022 will be hosted by University of Cape Town, South Africa. Scholarship Awards are available which support attendance for junior researchers from low resource settings.
